(Q44249354)

1 December 2017

title

Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain (English)

1 reference

1 December 2017

Vinay Parikh

1

1 reference

1 December 2017

Mohammad M Khan

series ordinal

2

1 reference

1 December 2017

Sahebarao P Mahadik

series ordinal

3

1 reference

1 December 2017

publication date

1 January 2003

1 reference

Journal of Psychiatric Research

1 December 2017

published in

1 reference

1 December 2017

volume

37

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

43-51

1 reference

Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous DNA adducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Chronic treatment with prolixin causes oxidative stress in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Effects of antipsychotics on cognitive behaviour in rats using the delayed non-match to position paradigm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Reactive oxygen species and the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Reactivity of various phenothiazine derivatives with oxygen and oxygen radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

The membrane hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Free radical scavenging enzyme activity and related trace metals in clozapine-induced agranulocytosis: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Haloperidol alters rat CNS cholinergic system: enzymatic and morphological analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Free radical pathology and antioxidant defense in schizophrenia: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Elevated plasma lipid peroxides at the onset of nonaffective psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Oxidative injury and potential use of antioxidants in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Impaired antioxidant defense at the onset of psychosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Enzymes of the antioxidant defense system in chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Free radical pathology in schizophrenia: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

The cognitive efficacy of atypical antipsychotics in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Omega-3 fatty acids in health and disease and in growth and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Do essential fatty acids play a role in brain and behavioral development?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Effects of haloperidol on antioxidant defense system enzymes in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900048-1

10.1016/S0022-3956(02)00048-1

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference